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Abstract 
  
Hedyotis corymbosa has been used for long time as an important component in 
several folklore medicine formula to clinically treat various types of cancer, including 
colorectal cancer (CRC). Previously, Hedyotis corymbosa ethanolic extract (HEE) which 
contain ursolic acid reported to inhibit CRC growth via induction of cancer cell apoptosis 
and blocked the cell cycle, preventing G1 to S progression where cyclin D highly espressed in 
this phase. 5-fluorouracil (5FU), the first line chemotherapy of colorectal cancer have had 
resistence and possessed several side effects such as neutropenia, immunosuppression, 
diarrhea, and also constipation. Therefore, the aim of this research is to conduct the 
antiproliferative effect and molecular analysis of HEE and its combination with 5FU. Molecular 
docking study was also done to approach the specific protein target of the compound. 
Antiproliferative effect was conducted by MTT assay, while cyclin D expression  was 
examined by immunofluorescence. The proliferative effect showed that both HEE and 5-FU 
had cytotoxic effect with IC50 value of 65 µg/mL and 90 µM respectively, meanwhile the 
combination of HEE and 5FU have synergism effect with CI = 0.48 on dose HEE = 22 µg/mL 
and 5FU = 6.25 µM. Immunofluorescence assay showed HEE and its combination with 5FU 
suppressed the expression of cyclin D. From molecular docking simulation, ursolic acid 
performed stable interaction with cyclin D. Our findings suggest that HEE may be an effective 
treatment for co-chemotherapic for 5-FU through inhibition of cyclin D expression. 
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INTRODUCTION 
 
Cancer cells are characterized by 
uncontrolled proliferation (Hanahan and 
Weinberg, 2011), therefore inhibiting this 
excessive proliferation is one of the key for the 
development of anticancer drugs. The transition 
from G1 phase of the cell cycle to S phase plays 
crucial role for the control of eukaryotic cell 
proliferation, and its misregulation promotes 
oncogenesis. During G1 phase, growth 
dependent cyclin-dependent kinase (CDK) 
activity promotes DNA replication and initiates 
G1 to S phase transition (Bertoli, et al., 2013). 
Colorectal cancer is one cancer type 
which becomes the third most commonly 
diagnosed cancer and the third leading cause of 
cancer death in both men and women. The 
prevalence of colorectal cancer has been 
incresed along the increasing human population 
(ACS, 2014). First line therapy for CRC, 5-
fluorouracil (5FU) has been become resistence 
despite its side effect like neutropenia, 
immunosuppression, cardiotoxicity and 
diarrhea (Denise, et al., 2015; Gressett, et al., 
2006; Sorrentino, et al., 2012).  
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Recently, natural products have received 
great interest since they have relatively few side 
effects compared with modern 
chemotherapeutics and have been used 
clinically for thousands of years as significant 
alternative remedies for a variety of diseases 
including cancer (Kellof, 2000; Jeune, et al., 
2005; Won, et al., 2006). 
One promising medicinal plant is 
Hedyotis corymbosa that belongs to the 
Rubiaceae family and is widely distributed 
throughout Souteast Asia. Hedyotis corymbosa 
which contain ursolic acid that has been 
reported to inhibit the growth of CRC through 
the induction apoptosis and the blocked the cell 
cycle on G1/S progression (Suparman, 2008). 
To further exploration the activity of Hedyotis 
corymbosa ethanolic extract (HEE), we investi-
gated its moleculer mechanism on the 
proliferation of human colon carcinoma WiDr 
cells through expression of cyclin D that 
regulated cell cycle on G1/S progression.  
 
MATERIALS AND METHODS 
 
Sample 
The herbs of Hedyotis corymbosa  were 
collected from around Universitas Gadjah 
Mada, Sleman, Yogyakarta. The plant was 
determined in Biological Pharmacy 
Labroratorium, Faculty of Pharmacy 
Universitas Gadjah Mada. The air-dried and 
ground leaves (300 g) were soaked in ethanol 
96% (3 L) for 72 h,  then the mixture was 
filtered to obtain the crude extract. The extract 
was concentrated using rotary evaporator under 
vacuum at room temperature to obtain a final 
residue (23 g) for further experiment. Sample 
was dissolved in Dimethyl Sulfoxide (DMSO) 
(Sigma). Both 5 mg/ml 5-FU (Kalbe) and HEE 
were then diluted in cell culture medium before 
being applied. DMSO was also used as the co-
solvent in dissolving samples in culture 
medium. 
 
Cell culture 
WiDr colorectal cells were obtained 
from Cancer Cancer Chemoprevention 
Research Center, Yogyakarta. The cells were 
grown and maintained in Roswell Park 
Memorial Institute (RPMI) 1640 (Gibco) 
supplemented with 10 % 
v
/v Fetal Bovine 
Serum (FBS) (Sigma) and 1% 10.000 UI/mL 
Penicillin-Streptomycin at 37
o
C in humidified 
atmosphere of 5 % CO2.  
 
MTT Cytotoxicity Assay 
Cell viability was determined by a 
microculture tetrazolium teachnique (MTT) 
assay according to the method by Mosmann 
(1983) with minor modifications. Briefly, WiDr 
cells were seeded into a 96-well plate (8 x 10
3
 
cells per well). After 48 h incubation with 
various concentration of HEE, 5-FU, and its 
combination, the medium was discarded and 
added with MTT reagent (0.5 mg/mL) 
(Biovision) 100µL to each well. The plate was 
incubated in a humidified atmosphere of 5% 
CO2 at 37
o
C for 4 h and then formazan crystals 
were dissolved in 100 µL of 0.01 N HCl and 
incubated in the dark for overnight. The 
absorbance of cells was measured at 595 nm by 
a microplate reader. Cells absorbance was 
converted to % cell viability. Linear regression 
between concentration and % cell viability 
giving the equation y = Bx + A were used to 
calculate IC50 value, that is the concentration 
inhibiting 50% cell proliferation. 
 
Immunofluorescence Assay 
Cells (5 x 10
4
 cells/well) were seeded on 
coverslip in 24 well plates until 80% confluent. 
Cells were treated with fresh medium contain 
HEE, 5FU, and the combination and incubated 
in 37
o
C for 24 h, cells were harvested and were 
washed using PBS and fixed it with 70% 
ethanol for 10 min at room temperature. After 
rinsed again with PBS, cells were incubated 
with blocking serum 1% BSA for 30 min at 
room temperature. Then, cells were incubated 
with primary antibody (anti-cyclin D) for 1 
hour at room temperature. After rinsed with 
PBS, cells were incubated with secondary 
antibody conjugated by FITC for 1 hour at 
room temperature in the dark. Then, cell were 
added by DAPI solution and incubated for 10 
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min at room temperature in the dark. After 
rinsed with PBS, cell were added with 
mounting solution (Fluoromount), put on slide 
glass, and store at 4°C. The protein expressions 
were observed under fluorescence microscope. 
 
RESULTS AND DISCUSSIONS 
 
Hedyotis corymbosa, 5-FU, and their 
combination Inhibited the proliferation 
of WiDr Cells 
Cell viability assay was done to 
determine the inhibitory effect of HEE and 5-
FU single treatment on WiDr cells. The single 
treatment of 5-FU for 48 h with range of 
concentration up to 90 μM revealed to possess 
cytotoxic effect in dose dependent manner. The 
cytotoxic effect was proven by morphological 
change on cells (shrinkage and fragmentation). 
Based on this study, 5-FU had cytotoxic effect 
by giving IC50 value of 90 μM. Interestingly, 
the treatment of single 5-FU in 24 h did not 
show significant inhibition on cells proliferation 
(data not shown), probably because of low 
sensitivity of WiDr cells toward 5-FU and high 
expression of timidilat sintetase (TS) on cells 
(Meyerhardt and Mayer, 2005; Giovannetti, et 
al., 2007). Moreover, 5-FU was also reported to 
induce  NF-κB expression which regulated anti-
apoptosis  transcription,  causing  cells  were 
able to escape the apoptosis (Peters, et al., 
2002).  
 
 
 
 
Figure 1. Cytotoxic effect of 5-FU on WiDr cells. Briefly 8x103  WiDr cells/well were seeded in 96 
well-plate and incubated for 24 h before treated with 5-FU for 48 h as described in methods. 
Cells viability was determined by using MTT assay as described in the methods. (A) Cell viability profile 
after single treatment of 5-FU for 48 h on WiDr cells. The cells morphological were shown above as (B) 
cell control, (C) 10 μM of 5-FU, (D) 40 μM of 5-FU. The cells were observe under inverted microscope 
with 100x magnification. Normal cells were marked as              meanwhile irregular cells were marked as                      
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The cytotoxic effect of Hedyotis 
corymbosa ethanolic extract (HEE) was also 
carried out for 48 h, based on several previous 
studies reported that the bioactive compound in 
HEE, ursolic acid revealed to give optimum 
cytotoxic effect after 48 h of treatment (Dong-
Kyoo, et al., 2000; Harmand, et al., 2005; Li, et 
al, 2010; Shisodia, et al., 2003). Similar to 5-
FU, the treatment with HEE showed inhibitory 
effect in dose dependent manner; given IC50 
value of 65 μg/mL. The morphological changes 
on cells was seen in higher concentration of 
HEE, indicated that HEE possessed cytotoxic 
effect toward WiDr cancer cells. 
Furthermore, the combination between 
HEE and 5-FU was carried out on WiDr cells to 
determine its combination effect on cells 
proliferation. Based on this study, the treatment 
of 5-FU and HEE exhibited synergistic effect 
on WiDr cells, given CI value less than 1, with 
lowest CI value was showed in combination of 
10 μg/mL HEE andd 1.25 μM 5-FU with CI 
value of 0.33. Based on MTT assay, it was 
demonstrated that the treatment of HEE in 
combination with 5-FU inhibited cells 
proliferation significantly, as the single 
treatment with 5-FU only inhibit cells 
proliferation up to 40%, when in combination 
with 40 μg/mL HEE could decreased cells 
viability up to 65%. Thus, HEE could be 
applied as co-chemoterapeutic agent to increase 
5-FU sensitivity on colon cancer. 
 
 
 
Figure 2.  Cytotoxic effect of HEE on WiDr cells. Briefly 8x103 WiDr cells/well were seeded in 96 well-plate 
and incubated for 24 h before treated with HEE for 48 h as described in methods. Cells viability was 
determined by using MTT assay as described in the methods. (A) Cell viability profile after single 
treatment of HEE for 48 h on WiDr cells. The cells morphological were shown above as (B) cell control, 
(C) 10 μg/mL of HEE, (D) 40 μM of HEE. The cells were observe under inverted microscope with 100x 
magnification.  
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Figure 3. The combination treatment of HEE and 5-FU after 48 h on WiDr cells. Briefly, 104 WiDr 
cells/well were seeded in 96-wellplate before treated with HEE and 5-FU and incubated for next 48 h as 
described in methods. The effect of combination treatment was determined as % of cells viability (n=3, 
p<0,05).  
 
Table 1. Combination Index (CI) value from combination treatment of HEE and 5-FU on WiDr cells 
for 48 h 
HEE (μg/ml) 
5-FU (μM) 
1,25 2,5 5 10 
5 0.86 0.61 0.82 0.60 
10 0.33 0.41 0.48 0.66 
20 0.36 0.53 0.50 0.67 
40 0.43 0.67 0.51 0.65 
 
 
Previous study had been reported that 
HEE caused cell cycle arrest on G1/S phase. 
Further mechanism has been conducted to 
evaluate cyclin D expression which regulated 
cell cycle in G1 to S transition by using 
immunofluorescence assay.  
This research suggests that HEE perform 
promising potency to be developed as co-
chemotherapeutic agent for CRC.  
 
 
Figure 4. Effect of 5-FU and HEE on cyclin D expression on WiDr Cells. Cells were gorwn on coverslips 
and treated with compounds as indicated in methods, then subjected to immunofluorescent staining with 
cyclin D and DAPI as described in materials and methods. Visualizations were done under microscope 
fluorescent with 400x magnification. 
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